preventive-health
(20)
Aktivo Labs
Aktivo Labs is a Singapore-based digital health-science company that turns everyday smartphone and wearable data into a proprietary digital biomarker, the Aktivo Score, a 1-99 measure of an individual's risk for chronic disease. It sells its platform to life and health insurers, reinsurers and employers, helping them run evidence-based wellness programs and understand population health risk. Founded in 2017, the company raised a US$10M Series A led by Mitsui & Co. in 2022 and operates across Asia-Pacific with expansion into the US, Europe and Japan.
Healthlane
Healthlane is an African preventive-health company (Y Combinator W20) that pairs a mobile app with a network of diagnostic laboratories to give people personalized health checkups and screening. Founded by Alain Nteff and Dr. Agbor Ashumanyi Ako, it grew out of the maternal-health service GiftedMom with a goal of catching disease early rather than treating it late.
Doctor Anywhere
Doctor Anywhere is a Singapore-headquartered, tech-led healthcare company founded in 2017 by Lim Wai Mun. It started as a telemedicine app that put a licensed doctor on a video call within minutes, then deliberately grew downward into the physical world - GP clinics, specialist practices, health screening and imaging suites, home visits, medication delivery and an in-app health marketplace. The company describes the result as a 'Hospital Anywhere' model: one app that carries a patient from a 2am sore throat to a knee surgeon, across Singapore, Malaysia, Thailand, Indonesia and the Philippines. It serves roughly 3 million users, sells to consumers, corporates and insurers, and has raised about US$176 million from investors including Asia Partners, Novo Holdings, Square Peg, EDBI, IHH Healthcare, Philips and Pavilion Capital.
Imagene Labs
Imagene Labs is a Singapore-based health-tech company that runs an enterprise-grade, cloud-based B2B genetic analytics platform. Using patented ancestry-based genetic risk analytics and ethnically-relevant reference datasets, it turns a simple saliva sample into DNA insights that fitness, beauty, nutrition and healthcare brands use to build personalized products and services. Its consumer-facing brand, Ori, packages these insights into fitness, skincare and nutrition DNA tests for the Asian market and beyond.
Naluri
Naluri is a Southeast Asian digital health company that helps employers and insurers predict, prevent and manage chronic and mental health conditions. Founded in Kuala Lumpur in 2017, it combines behavioural science, data science and licensed health coaches - psychologists, dietitians, fitness and financial coaches - inside a single app to deliver structured, clinically-informed care for conditions such as diabetes, heart disease, obesity, chronic stress, anxiety and depression. Its programmes span Employee Assistance (EAP), chronic disease management and crisis support, serving over 200 employer clients and more than one million members across the region.
Function Health
Function Health is an Austin-based membership platform that gives consumers direct access to 100-plus lab tests, optional full-body MRI scans, and AI-generated insights for a flat annual fee. Founded in 2021 and led by CEO Jonathan Swerdlin with physician co-founder Mark Hyman, the company sells a data-first, preventive approach to healthcare aimed at helping members catch problems early and track their biology over time. After a $298M Series B in November 2025 at a $2.5B valuation, Function has become one of the fastest-growing consumer health companies in the US.
GlycanAge
GlycanAge is a UK-registered, Croatian-founded longevity biotech that measures biological age by analyzing glycans - sugar molecules attached to immune-system antibodies. Built on roughly two decades of glycobiology research led by Professor Gordan Lauc, the company turns a finger-prick blood sample into a report on how fast a person is aging at the molecular level, plus a specialist consultation to guide lifestyle changes. It sells directly to consumers and is expanding its glycan biomarkers into hospitals and preventive-care systems.
DexaFit
DexaFit is a health-testing company that turns a quick, low-radiation full-body DXA scan into a broad picture of a person's health - body composition, bone density, visceral fat and metabolic markers. Its AI arm, DexaFit Dx, layers machine learning on top of those same scans to screen for major chronic diseases such as coronary artery disease and type 2 diabetes, aiming to catch them early and non-invasively. Founded in Chicago in 2011 and now operating dozens of centers, DexaFit pairs in-person testing with an app that translates results into longevity scores, disease-risk estimates and trackable goals.
InsideTracker
InsideTracker is a Cambridge, Massachusetts personalized health and wellness company (legally Segterra, Inc.) that turns your blood, DNA, and wearable data into a science-backed action plan. Founded in 2009 by MIT-trained scientist Dr. Gil Blander, the platform analyzes dozens of blood biomarkers, estimates your biological 'InnerAge,' and recommends specific foods, supplements, and lifestyle changes to optimize performance, healthspan, and longevity. It has become a favorite of athletes and quantified-self enthusiasts and integrates directly with Garmin, Fitbit, Oura, and Apple devices.
Nikolina Lauc
Nikolina Lauc is co-founder and CEO of GlycanAge, a UK-based longevity diagnostics company built on two decades of glycobiology research from her father's laboratory in Zagreb. A serial entrepreneur since 18, she runs a business that translates a blood-based glycan test into a biological age readout, and she has become one of the more visible operators pushing preventive-health testing into the consumer market.
Chloe Harrouche
Chloe Harrouche is the co-founder and CEO of The Lanby, a New York membership practice that reimagines primary care as a hospitality-led, relationship-driven experience. A University of Pennsylvania bioengineering graduate and former Deloitte healthcare strategy consultant, she built The Lanby around a simple bet: that primary care should feel less like a waiting room and more like a team that actually knows you. Members get a dedicated care trio - a lead physician, a wellness advisor, and a care manager - working from one coordinated plan.
Oluwasoga Oni
Oluwasoga Oni is the CEO and co-founder of MDaaS Global, the Nigerian healthtech company behind BeaconHealth Diagnostics, one of the country's fastest-growing diagnostic clinic networks. A software engineer turned MIT systems-engineering graduate, Oni grew up watching his father run a hospital in small-town Ondo State without the equipment he needed. He turned that memory into a company that started by importing refurbished medical machines and pivoted into building its own diagnostic centers, performing tens of thousands of tests and expanding across Lagos and underserved Nigerian cities. In 2026 the MIT Africa Business Club named him the recipient of its inaugural Alumni Impact Award.
DeLorean Artificial Intelligence
DeLorean Artificial Intelligence is a Palm Beach, Florida-based healthcare AI company that builds predictive and interventive intelligence to forecast chronic disease and recommend next-best clinical actions before a patient gets sicker. Its flagship Medical AI platform, MARTI, analyzes structured and unstructured health records to predict events like hospitalizations and disease progression - and is described as the first medical AI to be biologically validated by independent third parties. Founded in 2019 by Dr. Severence MacLaughlin, the company also applies its predictive engine to sales/CRM, life sciences, financial services and other industries.
Amanda Rees
Amanda Rees is the co-founder and CEO of Bold, a Los Angeles based digital fitness platform that delivers personalized, science-based exercise programs to help older adults build strength, ease pain, and prevent falls. A Princeton-trained chemical and biological engineer who is also a longtime dance and tai chi instructor, Rees built Bold after spending most of her twenties caring for her grandmother and discovering how few preventive tools existed for aging well. Bold partners with Medicare Advantage plans and has raised about $27 million in total funding, including a $17 million Series A.
Nucleus Genomics
Nucleus Genomics is a New York-based consumer genomics company that sells a $399 at-home, clinical-grade whole-genome sequencing kit and a software platform that turns a person's full DNA sequence into readable reports on disease risk, carrier status, traits, and longevity. Founded in 2021 by Thiel Fellow Kian Sadeghi, Nucleus pairs whole-genome data with polygenic risk scores and lifestyle inputs to estimate risk for common, complex conditions. In 2025 it expanded into reproductive products - carrier screening, partner DNA alignment, and a controversial embryo-ranking tool, Nucleus Embryo - that put the company at the center of a public debate over the science and ethics of genetic selection.
Tiny Health
Tiny Health is an Austin-based health company that built the first at-home gut microbiome test designed for babies, then extended the same clinically-validated science to children, pregnant people, adults and longevity. It pairs DNA sequencing of stool and vaginal samples with age-specific reference ranges and personalized, research-backed recommendations, aiming to catch early microbiome imbalances linked to eczema, allergies, digestive issues and chronic conditions before they take hold.
Andrew Lacy
Andrew Lacy is the Founder and CEO of Prenuvo, the company making proactive whole-body MRI scanning a mainstream healthcare tool. A Melbourne-born, Stanford-trained entrepreneur, he previously co-founded Tapulous - the mobile gaming company behind Tap Tap Revenge, acquired by Disney in 2010 - before pivoting to healthcare. At Prenuvo, he has raised $177M in total funding (including a $120M Series B in 2024), grown the company to 110,000+ members across 17 North American clinics, and secured FDA clearance for AI-powered body composition analysis, with plans to expand into Europe and Australia.
Prenuvo
Prenuvo runs a chain of clinics built around a 60-minute whole-body MRI designed to spot cancer, aneurysms and hundreds of other conditions before symptoms show up. Founded by Andrew Lacy and radiologist Raj Attariwala, the company is trying to drag American healthcare from reactive to preventive, one scan at a time.
Barton Wells
Barton Wells is the co-founder, CEO, and CTO of DexaFit Dx, a Palo Alto-based health technology company using AI and full-body DXA scans to detect coronary artery disease, Type 2 diabetes, and other chronic conditions early and non-invasively. A Stanford-trained mathematician and former world-ranked open water marathon swimmer, Wells brings 30+ years of AI, computer vision, and iOS engineering experience - spanning stints at Dropbox and multiple startups - to the challenge of transforming a 7-minute medical scan into a multi-disease risk screening platform for insurers, employers, and individuals.
Miray Tayfun
Miray Tayfun is the co-founder and CEO of Vivoo, a San Francisco-based health technology company that turns urine test strips into personalized wellness insights via a mobile app. A bioengineering graduate and serial founder, she built Vivoo from a personal frustration with expensive and slow health testing into a platform serving 300,000+ users across 50+ countries. Backed by Tim Draper and $19.4M in total funding, Vivoo expanded from subscription test strips to a $99 smart toilet unveiled at CES 2026, named Best of CES by Gadget Flow. Tayfun is a 2019 Australian Financial Review Top 100 Women of Influence honoree and 2018 Laureate Here for Good Award winner.